These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31018876)

  • 21. Improved Treatment Options for Glaucoma with Brimonidine-Loaded Lipid DNA Nanoparticles.
    Schnichels S; Hurst J; de Vries JW; Ullah S; Frößl K; Gruszka A; Löscher M; Bartz-Schmidt KU; Spitzer MS; Herrmann A
    ACS Appl Mater Interfaces; 2021 Mar; 13(8):9445-9456. PubMed ID: 33528240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brimonidine and brinzolamide for treating glaucoma and ocular hypertension; a safety evaluation.
    Lusthaus JA; Goldberg I
    Expert Opin Drug Saf; 2017 Sep; 16(9):1071-1078. PubMed ID: 28656780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developmental immaturity of the trabecular meshwork in congenital glaucoma.
    Tawara A; Inomata H
    Am J Ophthalmol; 1981 Oct; 92(4):508-25. PubMed ID: 7294114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chitosan nanoparticles for controlled delivery of brimonidine tartrate to the ocular membrane.
    Singh KH; Shinde UA
    Pharmazie; 2011 Aug; 66(8):594-9. PubMed ID: 21901982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drugs, Inflammation, and the Eye.
    Cunningham ET; London NJ; Moorthy R; Garg SJ; Zierhut M
    Ocul Immunol Inflamm; 2016; 24(2):125-7. PubMed ID: 27074544
    [No Abstract]   [Full Text] [Related]  

  • 26. A review of neuropsychiatric adverse events from topical ophthalmic brimonidine.
    Cimolai N
    Hum Exp Toxicol; 2020 Oct; 39(10):1279-1290. PubMed ID: 32347114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proniosomal gel-derived niosomes: an approach to sustain and improve the ocular delivery of brimonidine tartrate; formulation, in-vitro characterization, and in-vivo pharmacodynamic study.
    Emad Eldeeb A; Salah S; Ghorab M
    Drug Deliv; 2019 Dec; 26(1):509-521. PubMed ID: 31090464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pathological study on the deep scleral flap and external trabecular membrane obtained from non-penetrating trabecular surgery].
    Sun XH; Wang Y; Meng FR
    Zhonghua Yan Ke Za Zhi; 2003 Aug; 39(8):462-5. PubMed ID: 14642165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulse-Daylight-Photodynamic Therapy in Combination with Corticosteroid and Brimonidine Tartrate for Multiple Actinic Keratoses: A Randomized Clinical Trial.
    Wiegell SR; Johansen UB; Wulf HC
    Acta Derm Venereol; 2019 Feb; 99(2):242-243. PubMed ID: 30250962
    [No Abstract]   [Full Text] [Related]  

  • 30. Diadenosine tetraphosphate improves adrenergic anti-glaucomatous drug delivery and efficiency.
    Loma P; Guzman-Aranguez A; Perez de Lara MJ; Pintor J
    Exp Eye Res; 2015 May; 134():141-7. PubMed ID: 25701803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Brimonidine-induced interstitial keratitis: Case report].
    Szwarcberg L; Gabrielle PH; Guillarme-Sallit R; Creuzot-Garcher C; Arnould L
    J Fr Ophtalmol; 2024 Jun; 47(6):104122. PubMed ID: 38479333
    [No Abstract]   [Full Text] [Related]  

  • 32. The outflow pathway in congenital glaucoma.
    Maul E; Strozzi L; Muñoz C; Reyes C
    Am J Ophthalmol; 1980 May; 89(5):667-73. PubMed ID: 7377264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The evolving pharmacotherapeutic profile of brimonidine, an alpha 2-adrenergic agonist, after four years of continuous use.
    Cantor LB
    Expert Opin Pharmacother; 2000 May; 1(4):815-34. PubMed ID: 11249518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brimonidine tartrate for the treatment of glaucoma.
    Oh DJ; Chen JL; Vajaranant TS; Dikopf MS
    Expert Opin Pharmacother; 2019 Jan; 20(1):115-122. PubMed ID: 30407890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomarkers and special features of oxidative stress in the anterior segment of the eye linked to lens cataract and the trabecular meshwork injury in primary open-angle glaucoma: challenges of dual combination therapy with N-acetylcarnosine lubricant eye drops and oral formulation of nonhydrolyzed carnosine.
    Babizhayev MA
    Fundam Clin Pharmacol; 2012 Feb; 26(1):86-117. PubMed ID: 21883446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Histopathological study of trabecular meshwork after trabeculotomy in monkeys].
    Ito S; Nishikawa M; Tokura T; Yamane A; Yamagishi K; Miki H
    Nippon Ganka Gakkai Zasshi; 1994 Sep; 98(9):811-9. PubMed ID: 7976840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting Schlemm's Canal in the Medical Therapy of Glaucoma: Current and Future Considerations.
    Andrés-Guerrero V; García-Feijoo J; Konstas AG
    Adv Ther; 2017 May; 34(5):1049-1069. PubMed ID: 28349508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Results of Preoperative Use of Topical Brimonidine in Strabismus Surgery.
    Ucar F; Cetinkaya S
    J Ocul Pharmacol Ther; 2021 May; 37(4):230-235. PubMed ID: 33684337
    [No Abstract]   [Full Text] [Related]  

  • 39. Morphological variability of the trabecular meshwork in glaucoma patients: implications for non-perforating glaucoma surgery.
    Dietlein TS; Jacobi PC; Lüke C; Krieglstein GK
    Br J Ophthalmol; 2000 Dec; 84(12):1354-9. PubMed ID: 11090472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. mRNA in situ hybridization of TIGR/MYOC in human trabecular meshwork.
    Wang X; Johnson DH
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1724-9. PubMed ID: 10845592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.